CLINICAL_TRIALS
trial_result
· 2007-05-21
Clinical Trial Update: Duloxetine Stress Urinary Incontinence Efficacy and Safety Study [Phase 3]
Summary
A Phase 3 trial evaluating duloxetine for stress urinary incontinence has completed, assessing its efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Urinary Incontinence, Stress | Phase 3 | Status: COMPLETED